JAMP Digoxin tablets: One lot recalled due to possible oversized tablets which may pose overdose risk
Critical priority
What you should do
- 1Return your JAMP Digoxin 0.0625 mg tablets to your pharmacy for replacement as soon as possible.
- 2Until you can return them, continue to take your JAMP Digoxin but do not take tablets that look oversized (see image, which shows an oversized tablet on the left and proper-sized tablet on the right).
- 3If you are unsure whether your product is affected, check with your pharmacy.
- 4Contact a health care professional immediately if you or someone you are caring for experience serious side effects.
- 5Contact JAMP Pharma Corporation by calling toll-free at 1-866-399-9091, extension 501, or by email at custjamp@jamppharma.com, if you have questions about this recall.
The issue
Product safety
Affected product
JAMP Digoxin 0.0625 mg tablets (lot EG23DGX001, expiry 07-2025)
Where it was sold
Canada (national)Reported in the official notice — confirm there.
Issued by
Health Canada
Read the official Government of Canada notice
All recallsRecallGuardian ranks, illustrates and rewrites recalls in plain language. The official notice is authoritative — confirm model numbers, lot codes, dates and remedies there.